Abstract

Since the 1990 NIH-sponsored conference on polycystic ovary syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader spectrum of signs and symptoms of ovarian dysfunction than those defined by the original diagnostic criteria. The 2003 Rotterdam consensus workshop concluded that PCOS is a syndrome of ovarian dysfunction along with the cardinal features hyperandrogenism and polycystic ovary (PCO) morphology. PCOS remains a syndrome and, as such, no single diagnostic criterion (such as hyperandrogenism or PCO) is sufficient for clinical diagnosis. Its clinical manifestations may include: menstrual irregularities, signs of androgen excess, and obesity. Insulin resistance and elevated serum LH levels are also common features in PCOS. PCOS is associated with an increased risk of type 2 diabetes and cardiovascular events.

Keywords

Polycystic ovaryHyperandrogenismInsulin resistanceMedicineAndrogen ExcessGynecologyOvaryObesityInternal medicineEndocrinology

MeSH Terms

Clinical Trials as TopicConsensus Development Conferences as TopicConsensus Development ConferencesNIH as TopicFemaleHumansHyperandrogenismInsulin ResistanceLuteinizing HormonePolycystic Ovary SyndromeRisk FactorsUnited States

Related Publications

Publication Info

Year
2004
Type
article
Volume
81
Issue
1
Pages
19-25
Citations
8865
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

8865
OpenAlex
35
Influential
4498
CrossRef

Cite This

Chang J, Bouchard, P., Diamanti, E et al. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility , 81 (1) , 19-25. https://doi.org/10.1016/j.fertnstert.2003.10.004

Identifiers

DOI
10.1016/j.fertnstert.2003.10.004
PMID
14688154

Data Quality

Data completeness: 86%